Attached files
file | filename |
---|---|
EX-31.A - EX-31.A - DUSA PHARMACEUTICALS INC | y90065exv31wa.htm |
EX-32.B - EX-32.B - DUSA PHARMACEUTICALS INC | y90065exv32wb.htm |
EX-99.1 - EX-99.1 - DUSA PHARMACEUTICALS INC | y90065exv99w1.htm |
EX-31.B - EX-31.B - DUSA PHARMACEUTICALS INC | y90065exv31wb.htm |
EX-21.A - EX-21.A - DUSA PHARMACEUTICALS INC | y90065exv21wa.htm |
EX-23.A - EX-23.A - DUSA PHARMACEUTICALS INC | y90065exv23wa.htm |
10-K - FORM 10-K - DUSA PHARMACEUTICALS INC | y90065e10vk.htm |
EXHIBIT 32(a)
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of DUSA Pharmaceuticals,
Inc. (the Company) on
Form 10-K
for the year ended December 31, 2010, as filed with the
Securities and Exchange Commission (the
Report), I, Robert F. Doman, President and
Chief Executive Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:
1) The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
2) The information contained in the Report fairly presents,
in all material respects, the financial condition and results of
operations of the Company.
Date: March 3, 2011
|
/s/ Robert
F.
Doman Robert
F. DomanPresident and Chief Executive Officer (principal executive officer) |